I will be in Baltimore MD starting tomorrow Monday Nov 6 until Wednesday Nov 8 speaking at ⁦Johns Hopkins University⁩ ⁦Johns Hopkins Medicine⁩ ⁦Hopkins Press⁩ meeting with extraordinary friends and colleagues as well as the medical students and residents

amongst the best of Israel right here in this video

idsociety.org/news--publicat… via IDSA Changes are needed badly. Thank you IDSA for working on this

many reasons why life expectancy in US is falling. I have to imagine the painfully system for getting medications covered by insurance companies is one of them. Without A LOT of work on the part of patients there are a million ways that things don't work out.

share.transistor.fm/s/e9646ad0 new episode up: invasive candidiasis

Estimates of actual and potential lives saved in the United States from the use of COVID-19 convalescent plasma | PNAS pnas.org/doi/10.1073/pn…

Thank you to today’s panel of MMI Thursday Seminar presenters — David Sullivan, MD, & our guests from Johns Hopkins Medicine moderator Dan Hanley, MD, Shmuel Shoham, Nicole McBee & Karen Lane! Great interactive discussion about their multi-center #COVID-19 clinical trial

For a patient in whom there is a high pre-test probability for Clostridium difficile infection: a positive C difficile PCR with a negative EIA for toxin, does not rule out C difficile. False negative tests for the EIA toxin do occur.

Teaching case: middle aged man with ulcerative colitis. Disease has been stable, but now seemingly flares. CMV viral load ~100K. Endoscopy: CMV colitis. CMV IgG had been negative previously. Now CMV IgM+. This is probably primary CMV infection with tissue invasive disease

Candida auris: a) adheres to skin and inanimate objects, b) colonization often clinically significant (compared to C. albicans), c) associated with outbreaks, d) often resistant to fluconazole, and sometimes echinocandins too. A good review article by Lionakis in NEJM in 2024

Clinical situation: should you use vancomycin as part of empiric therapy in patient with AML and pneumonia. Answer from clinical trial: Not typically, if MRSA screen is negative - Talagtag - 2021 - Transplant Infectious Disease - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/ti…

Aspergillus tanneri fast facts: Tends to be resistant to multiple antifungal agents, described in people with chronic granulomatous disease (CGD) Western parts of US, living in Western parts of the US. Disseminated and contiguous disease patterns

hopkinsmedicine.org/infectious-dis… We are excited about this course. We are sure Contagion readers will find this course worthwhile

A great opportunity for those wanting to learn and update themselves about infections in transplant and oncology patients.

Two Pandemics, Compared: Reflections on HIV and COVID-19 blogs.jwatch.org/hiv-id-observa…

Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic study - The Lancet Microbe thelancet.com/journals/lanmi…